Opinion - Radiologic measurement of tumor size in clinical trials: Past, present, and future

被引：40

作者：

Saini, S

机构：

[1] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2001年 / 176卷 / 02期

关键词：

D O I：

10.2214/ajr.176.2.1760333

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：333 / 334

页数：2

共 6 条

[1] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer [J].

Blum, JL ;

Jones, SE ;

Buzdar, AU ;

LoRusso, PM ;

Kuter, I ;

Vogel, C ;

Osterwalder, B ;

Burger, HU ;

Brown, CS ;

Griffin, T .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :485-493

[2]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[3]

2-6

[4] MAGNETIC-RESONANCE-IMAGING IN THE EVALUATION OF CLINICAL-TRIALS IN MULTIPLE-SCLEROSIS [J].

PATY, DW ;

LI, DKB ;

OGER, JJF ;

KASTRUKOFF, L ;

KOOPMANS, R ;

TANTON, E ;

ZHAO, GJ .

ANNALS OF NEUROLOGY, 1994, 36 :S95-S96

[5] VOLUME DOUBLING MEASUREMENT OF SPHERICAL AND ELLIPSOIDAL TUMORS [J].

SPEARS, CP .

MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (03) :212-217

[6]

Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205

← 1 →